A Review of the Clinical and Epidemiologic Evidence Relevant to the Impact of Postdiagnosis Isoflavone Intake on Breast Cancer Outcomes.
- 2025-03-25
- Review
- Current nutrition reports 14(1)
- Mark Messina
- Sarah Nechuta
- PubMed: 40131602
- DOI: 10.1007/s13668-025-00640-5
- Low evidence
- Clinical
extensive clinical research indicates that neither soy foods nor isolated isoflavones affect markers of breast cancer risk including mammographic density and breast cell proliferation
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- approximately 50 mg isoflavones (two servings of traditional Asian soy foods daily)